Article
Exploring Epigenetic Modifications as Potential Biomarkers and Therapeutic Targets in Glaucoma
29 Feb 2024
Abstract excerpt
Glaucoma, a complex and multifactorial neurodegenerative disorder, is a leading cause of irreversible blindness worldwide. Despite significant advancements in our understanding of its pathogenesis and management, early diagnosis and effective treatment of glaucoma remain major clinical challenges. Epigenetic modifications, encompassing deoxyribonucleic acid (DNA) methylation, histone modifications, and non-coding...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
